Veeva Systems (VEEV) – Analysts’ Weekly Ratings Updates

Veeva Systems (NYSE: VEEV) has recently received a number of price target changes and ratings updates:

• 7/26/2026 – Veeva Systems was upgraded by Wall Street Zen from “hold” to “buy”.
• 7/23/2026 – Veeva Systems is now covered by Guggenheim. They set a “buy” rating and a $232.00 price target on the stock.
• 7/22/2026 – Veeva Systems was upgraded by Guggenheim to “strong-buy”.
• 7/20/2026 – Veeva Systems had its “outperform” rating reaffirmed by Oppenheimer Holdings, Inc..
• 7/18/2026 – Veeva Systems was downgraded by Wall Street Zen from “buy” to “hold”.
• 7/10/2026 – Veeva Systems was upgraded by Weiss Ratings from “sell (d+)” to “hold (c-)”.
• 6/25/2026 – Veeva Systems was downgraded by Weiss Ratings from “hold (c-)” to “sell (d+)”.
• 6/13/2026 – Veeva Systems was upgraded by Wall Street Zen from “hold” to “buy”.
• 6/4/2026 – Veeva Systems had its “outperform” rating reaffirmed by BNP Paribas Exane. They now have a $285.00 price target on the stock.
• 6/4/2026 – Veeva Systems had its “buy” rating reaffirmed by TD Cowen.
• 6/4/2026 – Veeva Systems had its price target lowered by Mizuho from $295.00 to $270.00. They now have an “outperform” rating on the stock.
• 6/4/2026 – Veeva Systems had its price target raised by Wells Fargo & Company from $317.00 to $320.00. They now have an “overweight” rating on the stock.
• 6/4/2026 – Veeva Systems had its “outperform” rating reaffirmed by Evercore Inc. They now have a $185.00 price target on the stock.
• 6/4/2026 – Veeva Systems had its price target lowered by Stifel Nicolaus from $245.00 to $230.00. They now have a “buy” rating on the stock.
• 6/4/2026 – Veeva Systems had its “outperform” rating reaffirmed by Raymond James Financial, Inc.. They now have a $225.00 price target on the stock.
• 6/4/2026 – Veeva Systems had its price target raised by Citigroup Inc. from $176.00 to $190.00. They now have a “neutral” rating on the stock.
• 6/4/2026 – Veeva Systems had its price target lowered by The Goldman Sachs Group, Inc. from $190.00 to $165.00. They now have a “sell” rating on the stock.
• 6/4/2026 – Veeva Systems had its “outperform” rating reaffirmed by Oppenheimer Holdings, Inc.. They now have a $225.00 price target on the stock.
• 6/4/2026 – Veeva Systems had its price target lowered by Canaccord Genuity Group Inc. from $235.00 to $220.00. They now have a “hold” rating on the stock.
• 6/4/2026 – Veeva Systems had its “outperform” rating reaffirmed by Royal Bank Of Canada. They now have a $275.00 price target on the stock.
• 6/4/2026 – Veeva Systems had its price target lowered by UBS Group AG from $220.00 to $190.00. They now have a “neutral” rating on the stock.
• 6/4/2026 – Veeva Systems had its price target lowered by BMO Capital Markets from $220.00 to $175.00. They now have a “market perform” rating on the stock.
• 6/4/2026 – Veeva Systems had its price target lowered by Barclays PLC from $250.00 to $235.00. They now have an “overweight” rating on the stock.
• 6/4/2026 – Veeva Systems had its price target raised by Robert W. Baird from $250.00 to $260.00. They now have an “outperform” rating on the stock.
• 6/4/2026 – Veeva Systems had its price target lowered by Piper Sandler from $285.00 to $235.00. They now have an “overweight” rating on the stock.
• 6/4/2026 – Veeva Systems had its “buy” rating reaffirmed by Needham & Company LLC. They now have a $270.00 price target on the stock.
• 6/4/2026 – Veeva Systems had its “buy” rating reaffirmed by BTIG Research. They now have a $340.00 price target on the stock.

Veeva Systems (NYSE: VEEV) is a cloud software company that develops industry-specific applications and data solutions for the global life sciences sector. Founded in 2007 and headquartered in Pleasanton, California, Veeva focuses on helping pharmaceutical, biotechnology, medical device and consumer health companies manage regulated content, clinical and regulatory processes, quality systems, and commercial operations in a compliant, cloud-native environment. The company completed its initial public offering in 2013 and has since expanded its product suite and international footprint.

Veeva’s product portfolio centers on its Vault platform and related application suites, which provide content and data management, clinical trial and regulatory workflows, quality management, and structured commercial capabilities such as customer relationship management and promotional content management.